NO308024B1 - Doseringsenhet omfattende tverrbundet polyhydroksylisk materiale for enzymatisk kontrollert medikamentfrigjøring - Google Patents

Doseringsenhet omfattende tverrbundet polyhydroksylisk materiale for enzymatisk kontrollert medikamentfrigjøring

Info

Publication number
NO308024B1
NO308024B1 NO950251A NO950251A NO308024B1 NO 308024 B1 NO308024 B1 NO 308024B1 NO 950251 A NO950251 A NO 950251A NO 950251 A NO950251 A NO 950251A NO 308024 B1 NO308024 B1 NO 308024B1
Authority
NO
Norway
Prior art keywords
amylase
alpha
dosage unit
crosslinked
drug release
Prior art date
Application number
NO950251A
Other languages
English (en)
Other versions
NO950251L (no
NO950251D0 (no
Inventor
Mircea A Mateescu
Yves Dumoulin
Louis Cartilier
Vincent Lenaerts
Original Assignee
Labopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labopharm Inc filed Critical Labopharm Inc
Publication of NO950251L publication Critical patent/NO950251L/no
Publication of NO950251D0 publication Critical patent/NO950251D0/no
Publication of NO308024B1 publication Critical patent/NO308024B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO950251A 1992-07-24 1995-01-23 Doseringsenhet omfattende tverrbundet polyhydroksylisk materiale for enzymatisk kontrollert medikamentfrigjøring NO308024B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91976292A 1992-07-24 1992-07-24
PCT/CA1993/000298 WO1994002121A1 (en) 1992-07-24 1993-07-22 Cross-linked polyhydroxylic material for enzymatically controlled drug release

Publications (3)

Publication Number Publication Date
NO950251L NO950251L (no) 1995-01-23
NO950251D0 NO950251D0 (no) 1995-01-23
NO308024B1 true NO308024B1 (no) 2000-07-10

Family

ID=25442612

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950251A NO308024B1 (no) 1992-07-24 1995-01-23 Doseringsenhet omfattende tverrbundet polyhydroksylisk materiale for enzymatisk kontrollert medikamentfrigjøring

Country Status (18)

Country Link
EP (1) EP0651634B1 (no)
JP (1) JP3647859B2 (no)
KR (1) KR100304997B1 (no)
AT (1) ATE137668T1 (no)
AU (1) AU668198B2 (no)
CA (1) CA2140032C (no)
CZ (1) CZ283395B6 (no)
DE (1) DE69302580T2 (no)
ES (1) ES2086949T3 (no)
FI (1) FI950301A0 (no)
GR (1) GR3020476T3 (no)
HU (1) HU221591B (no)
MX (1) MX9304459A (no)
NO (1) NO308024B1 (no)
NZ (1) NZ254048A (no)
PL (1) PL173249B1 (no)
RU (1) RU2136270C1 (no)
WO (1) WO1994002121A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2173818A1 (fr) * 1996-04-10 1997-10-11 Francois Chouinard Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
DE19640062B4 (de) 1996-09-28 2006-04-27 Lts Lohmann Therapie-Systeme Ag Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff
US5879707A (en) * 1996-10-30 1999-03-09 Universite De Montreal Substituted amylose as a matrix for sustained drug release
US5807575A (en) * 1997-02-14 1998-09-15 Rougier Inc. Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
ZA984336B (en) * 1997-05-21 1998-11-30 Warner Lambert Co Non-sedating acrivastine product
US5989589A (en) * 1997-10-24 1999-11-23 Cartilier; Louis Cross-linked cellulose as a tablet excipient
EP1244428A1 (en) 1999-12-06 2002-10-02 Edward Mendell Co., Inc. Pharmaceutical superdisintegrant
US6607748B1 (en) 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
TWI319713B (en) 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en) 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
ES2620293T3 (es) 2005-09-09 2017-06-28 Paladin Labs Inc. Composición de liberación sostenida de fármacos
WO2007055329A1 (ja) 2005-11-11 2007-05-18 Asahi Kasei Chemicals Corporation 徐放性固形製剤
EP2590636A1 (en) 2010-07-06 2013-05-15 Grünenthal GmbH Novel gastro- retentive dosage forms comprising a gaba analog and an opioid
WO2012007159A2 (en) 2010-07-14 2012-01-19 Grünenthal GmbH Novel gastro-retentive dosage forms

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3181998A (en) * 1960-08-12 1965-05-04 Joseph L Kanig Tablet disintegration
US3493652A (en) * 1962-09-14 1970-02-03 Charles W Hartman Controlled release medicament
SE420565B (sv) * 1974-06-06 1981-10-19 Pharmacia Ab Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel
DE3721574A1 (de) * 1987-06-30 1989-01-12 Kettelhack Riker Pharma Gmbh Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione

Also Published As

Publication number Publication date
FI950301L (fi) 1995-01-24
ES2086949T3 (es) 1996-07-01
WO1994002121A1 (en) 1994-02-03
FI950301A7 (fi) 1995-01-24
GR3020476T3 (en) 1996-10-31
NZ254048A (en) 1995-09-26
RU2136270C1 (ru) 1999-09-10
KR100304997B1 (ko) 2002-04-24
AU668198B2 (en) 1996-04-26
EP0651634A1 (en) 1995-05-10
CZ283395B6 (cs) 1998-04-15
JPH08502036A (ja) 1996-03-05
ATE137668T1 (de) 1996-05-15
FI950301A0 (fi) 1995-01-24
PL307234A1 (en) 1995-05-15
NO950251L (no) 1995-01-23
CA2140032A1 (en) 1994-02-03
NO950251D0 (no) 1995-01-23
AU4555993A (en) 1994-02-14
HUT75673A (en) 1997-05-28
PL173249B1 (pl) 1998-02-27
DE69302580T2 (de) 1996-09-26
DE69302580D1 (de) 1996-06-13
CZ15295A3 (en) 1995-09-13
JP3647859B2 (ja) 2005-05-18
HU9500197D0 (en) 1995-03-28
EP0651634B1 (en) 1996-05-08
MX9304459A (es) 1994-04-29
CA2140032C (en) 1999-01-26
HU221591B (hu) 2002-11-28

Similar Documents

Publication Publication Date Title
NO308024B1 (no) Doseringsenhet omfattende tverrbundet polyhydroksylisk materiale for enzymatisk kontrollert medikamentfrigjøring
NO953767D0 (no) Tverrbundet amylose som et binde-/opplösende middel i tabletter
BR9708772A (pt) "comprimidos famacêuticos de liberação controlada que contém um veìculo à base de amilose reticulada e hidróxi propil metil celulose"
NO20001042L (no) Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter
NO20004208D0 (no) Fornettet stivelse med høyt amyloseinnhold og med funksjonelle grupper som en matriks for frigivning av farmasøytiske midler
UA29400C2 (uk) Пластир для трансдермального введення нітрогліцерину та спосіб його виготовлення
ES2152979T3 (es) Sistema terapeutico transdermal que contiene estradiol.
NO964799D0 (no) Hydrofile kontakt-smelteklebemidler
ES2097145T3 (es) Metodo y dispositivo para la liberacion de farmacos en la piel.
RU95107880A (ru) Твердая фармацевтическая форма
ES2062022T3 (es) Composicion adhesiva antibacteriana.
DE59504270D1 (de) Retardtablette mit einem gehalt an diclofenac-na
DE69225053D1 (de) Zusammensetzungen auf der basis von collagen zur kontrollierten arzneistoffreisetzung
DK0804165T3 (da) Fast lægemiddelform med aktivt stof fordelt i polymert materiale

Legal Events

Date Code Title Description
MK1K Patent expired